FDA Contends Canadian API Maker Medisca Incorrectly Labeled Products
International Pharmaceutical Regulatory Monitor
The FDA issued a warning letter to Canadian-based API maker Medisca for mislabeling its products.
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
No comments:
Post a Comment